Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006

被引:52
作者
Yang, Yun-Liang [2 ]
Wang, An-Huei [1 ]
Wang, Chih-Wei [1 ]
Cheng, Wei-Ting [1 ]
Li, Shu-Ying [3 ]
Lo, Hsiu-Jung [1 ]
机构
[1] Natl Hlth Res Inst, Div Clin Res, Zhunan Town 350, Miaoli Cty, Taiwan
[2] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 300, Taiwan
[3] Ctr Dis Control, Div Lab Res & Dev, Taipei 115, Taiwan
关键词
Candida; susceptibility; resistance;
D O I
10.1016/j.diagmicrobio.2008.01.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Susceptibilities to amphotericin B and fluconazole of 964 Candida isolates collected in Taiwan Surveillance of Antimicrobial Resistance of Yeasts in 2006 were determined. There were 419 (43.5%) Candida albicans, 246 (25.5%) Candida tropicalis, 211 (21.9%) Candida glabrata, 62 (6.4%) Candida parapsilosis, 14 (1.5%) Candida krusei, and 12 (1.2%) others. Interestingly, 16 of the 17 amphotericin B-resistant isolates were non-albicans Candida species. The resistant rate to amphotericin B has decreased from 2.5% in 2002 to 1.8% in 2006. On the other hand, there were 132 C. tropicalis, 14 C. krusei, 10 C. albicans, and 9 C. glabrata isolates that had MICs to fluconazole >= 64 mu g/mL. The prevalence of isolates with such high MICs was significantly higher than that in 2002 (17.1% versus 1.9%). Our results further indicate that most of the isolates with MICs to fluconazole >= 64 mu g/mL exhibited the "trailing" phenomenon. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:175 / 180
页数:6
相关论文
共 50 条
  • [41] Evaluation of the Vitek 2 system for antifungal susceptibility testing of Candida auris using a representative international panel of clinical isolates: overestimation of amphotericin B resistance and underestimation of fluconazole resistance
    Siopi, Maria
    Pachoulis, Ioannis
    Leventaki, Sevasti
    Spruijtenburg, Bram
    Meis, Jacques F.
    Pournaras, Spyros
    Vrioni, Georgia
    Tsakris, Athanasios
    Meletiadis, Joseph
    JOURNAL OF CLINICAL MICROBIOLOGY, 2024, 62 (04)
  • [42] Amphotericin B Polymer Nanoparticles Show Efficacy against Candida Species Biofilms
    Alakkad, Abdulghani
    Stapleton, Paul
    Schlosser, Corinna
    Murdan, Sudaxshina
    Odunze, Uchechukwu
    Schatzlein, Andreas
    Uchegbu, Ijeoma F.
    PATHOGENS, 2022, 11 (01):
  • [43] Comparison of the Kidney Fungal Burden in Experimental Disseminated Candidiasis by Species of the Candida parapsilosis Complex Treated with Fluconazole, Amphotericin B and Caspofungin in a Temporarily Neutropenic Murine Model
    Szilagyi, J.
    Foeldi, R.
    Gesztelyi, R.
    Bayegan, S.
    Kardos, G.
    Juhasz, B.
    Majoros, L.
    CHEMOTHERAPY, 2012, 58 (02) : 159 - 164
  • [44] Antifungal Susceptibility to Amphotericin B, Fluconazole, Voriconazole, and Flucytosine in Candida Bloodstream Isolates from 15 Tertiary Hospitals in Korea
    Jung, Soak-In
    Shin, Jong Hee
    Choi, Hyun-Jung
    Ju, Min-Young
    Kim, Soo-Hyun
    Lee, Wee Gyo
    Park, Yeon-Joon
    Lee, Kyungwon
    ANNALS OF LABORATORY MEDICINE, 2012, 32 (06) : 426 - 428
  • [45] Synthesis, morphology and antifungal activity of nano-particulated amphotericin-B, ketoconazole and thymoquinone against Candida albicans yeasts and Candida biofilm
    Randhawa, Mohammad A.
    Gondal, Mohammed A.
    Al-Zahrani, Al-Hosain J.
    Rashid, Siddique G.
    Ali, Ashraf
    JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART A-TOXIC/HAZARDOUS SUBSTANCES & ENVIRONMENTAL ENGINEERING, 2015, 50 (02): : 119 - 124
  • [46] In vitro activity of caspofungin compared to amphotericin B, fluconazole, and itraconazole against Candida strains isolated in a Turkish University Hospital
    Arikan, S
    Sancak, B
    Hascelik, G
    MEDICAL MYCOLOGY, 2005, 43 (02) : 171 - 178
  • [47] Amphotericin B-Induced in vitro Postantifungal Effect on Candida Species of Oral Origin
    Ellepola, A. N. B.
    MEDICAL PRINCIPLES AND PRACTICE, 2012, 21 (05) : 442 - 446
  • [48] Candida tropicalis biofilm's matrix-involvement on its resistance to amphotericin B
    Fernandes, Tania
    Silva, Sonia
    Henriques, Mariana
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2015, 83 (02) : 165 - 169
  • [49] In vitro antifungal activity of phenothiazines and their combination with amphotericin B against different Candida species
    Galgoczy, Laszlo
    Bacsi, Andrea
    Homa, Monika
    Viragh, Mate
    Papp, Tamas
    Vagvoelgyi, Csaba
    MYCOSES, 2011, 54 (06) : E737 - E743
  • [50] Effect of 2-Phenylethanol as Antifungal Agent and Common Antifungals (Amphotericin B, Fluconazole, and Itraconazole) on Candida Species Isolated from Chronic and Recurrent Cases of Candidal Vulvovaginitis
    Majdabadi, Niloufar
    Falahati, Mehraban
    Heidarie-Kohan, Fariba
    Farahyar, Shirin
    Rahimi-Moghaddam, Parvaneh
    Ashrafi-Khozani, Mahtab
    Razavi, Tandis
    Mohammadnejad, Sina
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2018, 16 (03) : 141 - 149